Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

'Big blue is back': IBM shares surge on strong results, accelerating AI adoption

Published 24/01/2024, 22:26
Updated 25/01/2024, 16:36

(Updated - January 25, 2024 10:12 AM EST)

Shares of IBM (NYSE:IBM) jumped over 11% Thursday after the enterprise software maker reported better-than-expected earnings per share (EPS) and revenue for Q4.

The company posted a fourth-quarter EPS of $3.87, beating the consensus projection of $3.77. Revenue came in at $17.38 billion, while analysts were looking for $17.23 billion.

Of that, $7.51 billion was software revenue, up 3.1% year-over-year, though below the Wall Street expectations of $7.69 billion. Consulting segment revenue stood at $5.05 billion, up 5.8% from a year earlier, and compared to $5.11 billion expected by analysts.

IBM generated $4.6 billion in infrastructure revenue, up 2.7% YoY and above the projected $4.35 billion.

Adjusted gross margin for Q4 was 60.1%, compared to 58.6% in the year-ago quarter and the 58.8% expected by analysts. Free cash flow stood at $6.09 billion, 17% higher than in the same quarter last year. Analysts expected $5.37 billion.

"In the fourth quarter, we grew revenue in all of our segments, driven by continued adoption of our hybrid cloud and AI offerings,” said Arvind Krishna, IBM chairman and CEO.

“Client demand for AI is accelerating and our book of business for Watsonx and generative AI roughly doubled from the third to the fourth quarter.”

Looking ahead, IBM expects a free cash flow of $12 billion for the full fiscal year, better than the $10.92 billion estimated by analysts.

The software firm also expects its revenue to grow roughly around 4-6% in 2024, which is better than Wall Street expectations of about 3%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"We think the print and guide, especially FCF guide are positive for the story. Focus for IBM will be can they execute and show consistent growth on Software and can Consulting acceleration in CY24 sustain in the same zip code as their Consulting peers," analysts at Evercore ISI said in a note.

"Our sense is IBM remains an underappreciated AI beneficiary that should continue to work higher over the next few years."

Analysts at Evercore ISI also lifted the price target by $15 to $215 per share on the Outperform-rated stock.

Meanwhile, BofA Securities analysts raised their price target from $170 to $200 and reiterated a Buy rating. They said that given the strong cash flow trajectory they see the company delivering close to $13 billion in FCF in fiscal year 2025.

"Reiterate Buy as the turnaround at IBM (rev growth and FCF improvement) continues, with a defensive portfolio, attractive dividend yield and underappreciated AI portfolio," BofA analysts added.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.